Zapotocky, M., Ryall, S., Fukuoka, K., Stucklin, A. G., Bennett, J., Sumerauer, D., Pavelka, Z., Cruz, O., Solano, P., Garre, M. L., Hauser, P., Frappaz, D., Hansford, J., Amayiri, N., Morse, H., Sabel, M., Bechensteen, A. G., Su, J., Karajannis, M., Finlay, J., Eisenstat, D., Canete, A., Toledano, H., Dahiya, S., Leary, S., Nicolaides, T., Finch, E., Mueller, S., Levy, J. M., Ellison, D., Lassaletta, A., Larouche, V., Ramaswamy, V., Dirks, P., McKeown, T., Bartels, U., Bouffet, E., Hawkins, C., Tabori, U., & , (n.d.). lGG-59. REMARKABLE OBJECTIVE RESPONSE AND FAVORABLE SURVIVAL FOR BRAF-V600E CHILDHOOD LOW-GRADE GLIOMAS TO BRAF INHIBITORS COMPARED CONVENTIONAL CHEMOTHERAPY. Neuro-oncology, 20(2), i117. http://access.bl.uk/ark:/81055/vdc_100095324625.0x000015